- Solve real problems with our hands-on interface
- Progress from basic puts and calls to advanced strategies
Interactive Options Course
Finance Courses and Lessons
Topics
Language
Finance Courses and Lessons
Topics
Language
Posted July 21, 2026 at 3:28 am
Investopedia is partnering with All Star Charts on this newsletter. Â The contents of this newsletter are for informational and educational purposes only.
US Bancorp spent four years stuck under one price. Every rally since 2021 died at the same spot. This week it finally broke through.
That is the kind of move that gets our attention, because a level that rejects a stock over and over for four years is not random. It is real supply, real sellers, and clearing it means those sellers are finally gone.
And US Bancorp is not doing it alone. Financials are putting in some of the best relative strength in the market right now, which just means they are outperforming the broader market, holding up better on the down days and pushing harder on the up days. Banks led it first. Asset managers are joining them now, and healthcare is starting to firm up right behind them.
Here are three names on our watchlists riding that strength.
US Bancorp (USB)
US Bancorp comes from our All-Star Charts premium list, where banks have been showing some of the strongest relative strength on our screens.
This is a massive multi-year base breakout, with price pushing through 63.50. That level capped every rally attempt since 2021. A base is the long sideways range a stock builds while buyers and sellers fight it out, and the longer the base, the more meaningful the breakout when it finally clears.
As long as USB holds above that former ceiling, we like it long here, with a first target up at 86.
Invesco (IVZ)
Invesco comes from our Apex Trader watchlist, and it fits right in with the strength we are seeing across financials.
This is a multi-year reversal pattern putting the finishing touches on completion. Price is now clearing a key former resistance level marked by the 61.8% retracement of the 2014 to 2020 decline. That retracement level is a spot chart readers watch closely, because reclaiming it signals a real trend change rather than just a bounce.
As long as IVZ holds 28, we like it long here, with a first target back at the old highs around 42. Asset managers are joining the banks in showing real leadership, and these are exactly the stocks we want to lean into.
Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb comes from our Breakout Multiplier watchlist, where healthcare has been firming up and showing signs of leadership.
Price is breaking through a tight coil at the upper bounds of its channel, setting the stage for a new leg higher. A coil is what you get when a stock trades in a tighter and tighter range, with volatility compressing until it has to release.
Volatility has been muted over the past few weeks, and we believe a new phase of expansion is right around the corner.
The Takeaway
One breakout is a stock. Three breakouts from the same corner of the market is a theme. Banks, asset managers, and now healthcare are all stepping up at the same time, and that is exactly the kind of rotation we want to be in front of.
P.S. Earnings season is kicking off in full gear this week. If you ever wanted to know the best way to trade them, join Kenny Glick this Wednesday at 11 am ET. Register here.
—
Originally posted 20th July 2026
Investopedia.com: The comments, opinions and analyses expressed herein are for informational purposes only and should not be considered individual investment advice or recommendations to invest in any security or to adopt any investment strategy. While we believe the information provided herein is reliable, we do not warrant its accuracy or completeness. The views and strategies described on our content may not be suitable for all investors. Because market and economic conditions are subject to rapid change, all comments, opinions and analyses contained within our content are rendered as of the date of the posting and may change without notice. The material is not intended as a complete analysis of every material fact regarding any country, region, market, industry, investment or strategy. This information is intended for US residents only.
Information posted on IBKR Campus that is provided by third-parties does NOT constitute a recommendation that you should contract for the services of that third party. Third-party participants who contribute to IBKR Campus are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.
This material is from Investopedia and is being posted with its permission. The views expressed in this material are solely those of the author and/or Investopedia and Interactive Brokers is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to buy or sell any security. It should not be construed as research or investment advice or a recommendation to buy, sell or hold any security or commodity. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Related Articles
Join The Conversation
For specific platform feedback and suggestions, please submit it directly to our team using these instructions.
If you have an account-specific question or concern, please reach out to Client Services.
We encourage you to look through our FAQs before posting. Your question may already be covered!